Stoke Therapeutics (STOK) Change in Receivables (2024 - 2026)

Stoke Therapeutics' Change in Receivables history runs 3 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

• In Q1 2026, Change in Receivables fell 212.15% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$3.8 million (changed N/A YoY), while the FY2025 annual figure was $4.3 million, up 8436.0% from the prior year.
• Change in Receivables for Q1 2026 stood at -$1.5 million, up from -$3.3 million in the prior quarter.
• The five-year high for Change in Receivables was $1.3 million in Q1 2025, with the low at -$3.3 million in Q4 2025.
• The 3-year median for Change in Receivables is -$892000.0 (2024), against an average of -$942750.0.
• The sharpest annual moves came in 2025 and 2026: Change in Receivables slumped 1011.41% in 2025, then slumped 212.15% in 2026.
• Stoke Therapeutics' Change in Receivables stood at -$298000.0 in 2024, then plunged by 1011.41% to -$3.3 million in 2025, then jumped by 55.13% to -$1.5 million in 2026.
• Business Quant data shows STOK's Change in Receivables at -$1.5 million in Q1 2026, -$3.3 million in Q4 2025, and $1.3 million in Q1 2025.